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Abstract
Background: Lymphatic filariasis (LF) has been targeted by the WHO for global eradication leading to the implementation
of large scale intervention programs based on annual mass drug administrations (MDA) worldwide. Recent work has
indicated that locality-specific bio-ecological complexities affecting parasite transmission may complicate the prediction of
LF extinction endpoints, casting uncertainty on the achievement of this initiative. One source of difficulty is the limited
quantity and quality of data used to parameterize models of parasite transmission, implying the important need to update
initially-derived parameter values. Sequential analysis of longitudinal data following annual MDAs will also be important to
gaining new understanding of the persistence dynamics of LF. Here, we apply a Bayesian statistical-dynamical modelling
framework that enables assimilation of information in human infection data recorded from communities in Papua New
Guinea that underwent annual MDAs, into our previously developed model of parasite transmission, in order to examine
these questions in LF ecology and control.
Results: Biological parameters underlying transmission obtained by fitting the model to longitudinal data remained stable
throughout the study period. This enabled us to reliably reconstruct the observed baseline data in each community.
Endpoint estimates also showed little variation. However, the updating procedure showed a shift towards higher and less
variable values for worm kill but not for any other drug-related parameters. An intriguing finding is that the stability in key
biological parameters could be disrupted by a significant reduction in the vector biting rate prevailing in a locality.
Conclusions: Temporal invariance of biological parameters in the face of intervention perturbations indicates a robust
adaptation of LF transmission to local ecological conditions. The results imply that understanding the mechanisms that
underlie locally adapted transmission dynamics will be integral to identifying points of system fragility, and thus
countermeasures to reliably facilitate LF extinction both locally and globally.
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Introduction
Lymphatic filariasis (LF), a highly debilitating vector-borne
macroparasitic disease of humans, has been targeted by the World
Health Organization (WHO) for global eradication [1–5]. This
has led to the rapid development and financing of large scale
national-level intervention programs based primarily on annual
mass drug administrations (MDA), which has led to impressive
reductions in LF infection prevalences in endemic populations
globally [6]. However, as infection levels have fallen in endemic
communities, questions have been raised regarding the need for
improved understanding of the dynamical processes that underlie
infection persistence and extinction dynamics, and hence the
controllability or eradicability of the disease [7–11]. A practical
question in this regard revolves around the nature of LF extinction
dynamics, including the numerical values of LF transmission/
infection endpoints in endemic communities, the resolution of
which is key to reliably determining when parasite transmission
has been interrupted and interventions can therefore be stopped
[12].
Our previous work has highlighted that both inherent
complexity in transmission dynamics and parameter uncertainty
can confound the prediction of extinction endpoints for compli-
cated parasitic systems, such as LF [7,9,11–13]. In particular, this
work has showed that complex ecological dynamics due to high
sensitivity to initial conditions and other locally varying climatic
and geographic factors mean that parasite transmission dynamics
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is likely to be highly variable in space and time [12], with the result
that LF infection endpoints or breakpoints (e.g. threshold values of
the microfilaria (mf) prevalence in humans below which infection
cannot sustain itself) may vary considerably from site to site.
Although it was shown that between-site heterogeneities in a few
biological and socio-ecological parameters controlling the intensity
and distribution of worm burdens in the human host population
may underlie this variability, the results also demonstrated that a
significant source of the variability reflects uncertainties surround-
ing parameter values of key transmission variables [12]. While a
part of this uncertainty reflects epistemic uncertainty regarding
transmission heterogeneity, it is clear that a major portion is also
due to the limited quantity and quality of site-specific data used to
develop/run existing models [12,14,15]. This implies that
reducing parameter uncertainty will require the need for data-
model integration methods that can assimilate information and
update initial parameter values as new information regarding LF
transmission dynamics becomes available either from different
sites or over time from individual sites [7,9,11–13,15–18].
In the context of the current initiative to eradicate LF, effective
model updating using longitudinal infection data from sites
undergoing interventions serves another crucial function, viz.
providing an important means to investigate possible temporal
patterns in the data. A particular focus in this regard of direct
import to managing LF eradication is the determination of
whether the updating of initial model fits (to baseline infection
data) using follow-up data after the start of interventions will result
in significantly altered estimates, particularly in the critical
biological parameters underlying parasite transmission. If this
occurs to the extent of bringing about dynamical behaviour
changes, then it may raise the real possibility of the emergence of
temporally varying endpoints as parasite interventions proceed.
The outcome of such a qualitative change in overall system
dynamics will, by affecting attractors, basins of attraction and
stability, be that LF endpoints could become dynamic ‘moving’
targets. The implication of such changes for LF elimination may
be the prolonging of interventions in some settings, while in others
we may need to develop and implement other adaptive control
strategies, including supplementation by vector control or with
more frequent mass treatments. If on the other hand, model
updates show that values of critical biological parameters
underpinning transmission do not vary appreciably or are robust
in response to the effect of interventions, then it might be possible
to derive estimates of transmission endpoints from post-interven-
tion monitoring data. This will be a significant step forward in the
management of elimination efforts against LF since it would allow
the estimation of target endpoints for interventions even in the
absence of baseline infection data for those sites which have only
post-intervention monitoring data. Such results would also
facilitate uncovering of the environmental or other conditions
that constrain or bound the transmission and extinction dynamics
of LF to an endemic setting [19,20]. This will in turn enable
insights into countermeasures that can disrupt the local robustness
in transmission, increase system fragility and more reliably push
the locally adapted transmission system into extinction [19,21–23].
Sequential calibration/updating of LF transmission models
using post-intervention follow up data on infection levels could
also produce additional information relevant to predicting the
impacts of interventions. For example, such model updates will be
important for a more direct estimation and evaluation of drug
related parameters, such as worm and mf killing efficacies,
reduction in worm fecundity, and drug lasting effects that impact
the duration of suppression in mf production [10,24–26]. Present
estimates of these effects are still largely based on best guestimates
[7]; better attempts to quantify such parameters using field data is
thus a distinct need and will be critical to improving control
predictions and hence intervention planning in endemic localities.
In a similar vein, the sequential fitting of models to follow-up
data could additionally offer the potential for allowing the
backward estimation of pre-control baseline infection patterns.
Reconstructions of historical baseline infection patterns (particu-
larly in terms of age-profiles of mf prevalence levels) will be
important because many LF intervention monitoring sites
currently do not have such data even though this information is
clearly essential for predicting trajectories in infection declines
from baseline levels as a result of applied interventions [27,28],
which will be essential for evaluating if interventions are
progressing as expected [27,29].
Here, we report on our efforts to undertake a first systematic
examination of each of the above issues in the context of a detailed
field trial to evaluate the impact of MDA for reducing LF infection
in endemic communities from the Dreikikir region of Papua New
Guinea [30]. We begin by first describing the extension and use of
a recently developed numerical modelling and Bayesian Melding
data-model integration tool to sequentially fit the Anopheles-
mediated LF transmission model [11] to baseline and follow-up
human mf age-prevalence data recorded from each of our
Dreikikir study communities. We then use the modelling results
to address the following set of specific questions: 1) do biological
parameters controlling LF transmission remain stable (with
regards to baseline estimates) in the face of the specific
interventions implemented in each community; 2) is it possible
to use the fits to data from each intervention period to reliably
perform backward extrapolation to reconstruct baseline age-
infection patterns; 3) is it possible to use the post-intervention
infection monitoring data to estimate LF transmission/infection
breakpoints consistent with those estimated using baseline only
data; and 4) can the modelling and fitting framework developed in
this study allow better estimates of drug treatment-related
parameters, including determination if such parameters may also
vary in their values between treatment populations? We end by
discussing the significance of the findings regarding the ecological
factors that may underlie LF transmission and extinction dynamics
in local settings, the importance of good quality intervention
monitoring data, including drug coverage information, and the
value of the applying the Bayesian model-data assimilation method
used here, for guiding the WHO-directed program to achieve the
eradication of LF globally.
Materials and Methods
Data
The data used in this analysis represent baseline and annual
follow-up monitoring data on changes in lymphatic filariasis
infection prevalences obtained from five communities (Peneng,
Albulum, Yauatong, Nanaha and Ngahmbule) in the Dreikikir
region of Papua New Guinea (PNG) [30–34]. These data were
collected as part of an open-label field study to compare the
population impacts of a single annual mass administration of
diethylcarbamazine plus ivermectin (DEC+IVR) with that of a
single annual dose of DEC alone for reducing LF infection
transmitted by anopheline mosquitoes. The data on individual
host mf status for the baseline period was collected in 1994 before
the start of mass treatment intervention and thereafter at the end
of one-year intervals for a period of 5 years [34]. Three of the five
villages (Peneng, Albulum, and Yauatong) were classified as high
transmission communities and the remaining as exposed to a
moderate rate of transmission based on annual mosquito biting
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rates [30–32]. Annual population sizes, totals of individuals
sampled, numbers of mf-positives out of these samples, yearly
drug coverages and the drug regimen for each of these villages, are
provided in Table 1. Infection status of individuals were assessed
using 1 ml of blood, whereas prevailing vector abundances (in
terms of annual biting rates per person) were determined using
man landing catches in all communities [30,31]. Note that as per
WHO guidelines at the time of the field trials, individuals under
five years of age were excluded from treatment with drugs during
the MDA period in any of these villages [30].
Methods
Deterministic model of anopheline-mediated LF
transmission. We employed the recently developed Anopheles-
vectored transmission model of LF to carry out the modelling work
in this study [7,9,11,12]. Briefly, the state variables of this hybrid
coupled partial differential and differential equation model vary
over age (a) and/or time (t), representing changes in the adult
worm burden per human host (W (a,t)), the mf level in the human
host modified to reflect infection detection in a 1 ml blood sample
(M(a,t)), the average number of infective L3 larval stages per
mosquito (L), and a measure of immunity (I(a,t)) developed by
human hosts against L3 larvae. The state equations comprising
this model are:
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The above equations involve partial derivatives of three state
variables (W - worm load; M - microfilaria intensity; I - immunity
to acquiring new infection due to the pre-existing worm load),
whereas given the faster time scale of infection dynamics in the
vector compared to the human host, the infective L3-stage larval
density in mosquito population is modeled by an ordinary
differential equation. This basic coupled immigration-death
structure of the model, as well as our recent extensions to reflect
transmission by anopheline mosquitoes in endemic areas, such as
in the Dreikikir region in PNG, have been extensively discussed
previously [7,11,12,35,36]. The parameters and functions of the
model and L* are described in Table 2.
Note that the biological parameters of the model are classified
into site-specific and site-invariant parameters, based on results
from our previous work which suggest that it is useful to distinguish
between biological parameters specific to the disease, and which
therefore can be assumed to apply to parasite and vector
populations that range over extended geographical areas, and
those which vary between localities [12,49].
The Bayesian Melding Framework
Our strategy was essentially to integrate follow-up field
observations on LF infection in populations undergoing mass
drug treatments with simulation model outputs to, firstly, update
the uncertainty in model parameters, and then use the calibrated
model to examine: (1) the stability of transmission-driving
parameters in the face of mass treatments, and (2) the utility of
sequential model fits to allow reliable back-extrapolation of
baseline infection dynamics as well as estimation of infection
endpoints and drug treatment-related parameters. We used the
statistical framework founded on the Bayesian Melding (BM)
algorithm to address this sequential model-fitting and analysis
problem [50–55].
The BM approach may be described as a procedure whereby
two priors on a model output are compared and ‘‘melded’’ together
in order to obtain the posterior parameter space in which the
model may reliably explain the underlying natural system
dynamics [52,56]. One of the priors on model output is the set
of observed data; for example, in our case the survey data on LF
prevalence collected from each endemic community before the
Table 1. Annual survey data for lymphatic filariasis (LF) mf prevalence for each of the five PNG study villages used in this work.
High Transmission Zone Low Transmission Zone
Village Peneng Albulum Yauatong Nanaha Ngahmbule
Regimen DEC+IVR DEC+IVR DEC alone DEC+IVR DEC alone
ABR 8194 42328 37052 11611 4346
Year T (PS) Mf+ C T (PS) Mf+ C T (PS) Mf+ C T (PS) Mf+ C T (PS) Mf+ C
1993–94 63(69) 42 n/a 50(71) 40 n/a 131(169) 121 n/a 211(281) 116 n/a 346(428) 177 n/a
1994–95 65(67) 40 50.38 60(60) 44 61.54 144(145) 104 66.19 238(247) 115 71.60 343(353) 118 70.24
1995–96 88(89) 18 77.98 69(69) 26 63.46 111(113) 58 57.75 208(210) 57 65.80 299(308) 79 60.69
1996–97 89(89) 12 75.21 70(70) 18 66.35 123(123) 44 62.57 196(211) 26 62.82 318(323) 30 65.20
1997–98 92(92) 5 68.42 75(75) 11 58.20 138(138) 27 65.85 221(224) 2 66.77 235(236) 11 47.44
1998–99 109(109) 4 71.92 64(64) 3 52.89 91(91) 8 43.69 166(172) 1 49.40 290(294) 5 56.40
Table keys: ABR - Annual Biting Rate (average number of mosquito bites per person per year); T - the total number of individuals sampled, with the bracketed numbers
showing the total population sizes (PS) of the study villages; Mf+ - the number of mf-positive samples out of the total individuals sampled; C - population-level drug
coverage, the percentage (%) of people who took the prescribed drug regimen during annual mass drug treatments; DEC - diethylcarbamazine; IVR – ivermectin. The
baseline survey was done in 1993–94. The 5-year intervention period ranged from 1994–95 through 1998–99. Wherever required in the paper, the post-intervention
years are indicated by Year 1 (i.e., 1994–95) through Year 5 (i.e., 1998–99).
doi:10.1371/journal.pone.0067004.t001
Modelling the Effects of Mass Drug Treatments
PLOS ONE | www.plosone.org 3 June 2013 | Volume 8 | Issue 6 | e67004
Table 2. Description the basic LF model parameters and functions used in the model.
Parameter Definition (units) Range Source
Intrinsic Biological parameters
l Number of bites per mosquito (per month) [5,15] [11,12,37,38]
y1 Proportion of L3 leaving mosquito per bite [0.12, 0.7] [39]
y2s2 The establishment rate
1 [0.0000398, 0.00364] [11,12,40]
m The worm mortality rate (per month) [0.008, 0.018] [11,12,41–44]
a Production rate of microfilariae per worm (per month) [0.25, 1.5] [11,12,39]
c The death rate of the microfilariae (per month) [0.08, 0.12] [12,39,43]
g Proportion of mosquitoes which pick up infection when biting an infected host [0.259, 0.481] [12,45]
s Death rate of mosquitoes (per month) [1.5, 8.5] [12,40]
k Maximum level of L3 given mf density [3.955, 4.83] [12]
c Strength of acquired immunity [0.0000003, 0.0109] [12]
d Immunity waning rate (per month) [0, 0.000001] [12]
Extrinsic Biological parameters
V/H Ratio of number of vector to hosts MBR/l [12], data
Hlin A threshold value used in h(a) to adjust the rate at which individuals of age a are
bitten: linear rise from 0 at age zero to 1 at age Hlin in months (h(a) = a/Hlin for a,Hlin;
h(a) = 1 otherwise)
[12, 240] months [12,36]
r Gradient of mf uptake2 [0.0495, 0.22] [12]
IC Strength of immunosuppression
3 [0.5, 5.5] [12]
SC Slope of immunosuppression function
4 (per worm/month) [0.01, 0.19] [12]
k0 The basic location parameter of negative binomial distribution used in aggregation
parameter (k= k0+kLinM)
[0.000036, 0.00077] [12,46,47]
kLin The linear rate of increase in the aggregation parameter defined above [0.00000024, 0.282] [12,46,47]
Drug’s efficacy related parameters & Coverage
v Worm killing efficacy (instantaneous) [0.1, 0.85] [7]
e Microfilariae killing efficacy (instantaneous) [0.55, 0.95] [7]
dreduc Reduction in the worm’s fecundity over a period of time P [0.55, 0.95] [7]
P A time period during which the drug remains efficacious in reducing the fecundity
of the surviving adult worms
[1,6] [7]
C Percentage of the populations of the study villages administered the drug [43.69, 77.98] data
Description of the functions used in the model
Function Definition5 Parameters Source
p(a) Probability that an individual is of age a Human age a in month [12,36]
Q(W,k) Adult worm mating probability k – negative binomial aggregation
parameter
[11,12,48]
g1(I) Immunity to larval establishment c – strength of immunity to larval
establishment
[12]
g2(W) Host immunosuppression IC – strength of
immunosuppression; SC – slope of
immunosuppression
[12]
f(M) Population-averaged vector uptake function k – maximum level of L3 given mf
intensity; r – gradient of mf uptake
[11,12]
1The proportion of L3-stage larvae infecting human hosts that survive to develop into adult worms [12].
2The gradient of mf uptake r is a measure of the initial increase in the infective L3 larvae uptake by vector as M increases from 0 [12,36].
3The facilitated establishment rate of adult worms due to parasite-induced immunosuppression in a heavily infected human host.
4The initial rate of increase by which the strength of immunosuppression is achieved as W increases from 0 [8].
5Mathematical expressions of the 5 functions:
p(a)~0:0361 exp½{0:0304a; w(W ,k)~1{ 1zW
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M
k
(1{ exp½{r=k)
 k{ 1
1z
M
k
(1{ exp½{2r=k)
 k
2
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3
7775:
All the intrinsic and extrinsic biological parameters, except V/H, described in this table are estimated. The V/H is adjusted in way that lV=H returns the value of monthly
biting rate (MBR). The four drug-related parameters are also estimated. The annually observed population-level MDA coverage C, on which information is available, is
used as an input during the model runs for the mass drug intervention. The functions, except p(a), described above contain one or two model parameters as well as one
of the state variables (W, M, I) describing infection in humans. The L* represents the average number of infective L3 larval stages per mosquito at the endemic situation.
doi:10.1371/journal.pone.0067004.t002
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start and during the implementation of a mass drug treatment
program. The other output prior is the model generated values of
the state variables, such as W or M. Thus, the BM procedure is a
method for reconciling several sources of prior information (on
both input parameters and on model outcomes relative to data) to
constrain the acceptable solution space of the input parameters. In
the form of the method we implemented here, we initially assigned
vague or uniform prior distributions for each of the model input
parameters (except for the mosquito biting rate, which was fixed to
the values of the monthly biting rate (MBR; see Table 2) measured
at baseline in the study data) to reflect our initial incomplete
knowledge regarding their values, while for assessing reasonable-
ness of model outputs to data, a binomial likelihood function was
constructed to capture the distribution of the observed age-mf
prevalence data:
L(h)~P
age
S!
S! S{Mð Þ!Page
M 1{Page
  S{Mð Þ
,
where M is the total microfilaraemic (i.e. mf positives) samples out
of the total S blood samples collected from people in the ageth age-
group, and the term Page is the modelled mf prevalence in the
same age-group. The h represents a set of the model parameters,
termed as parameter vector.
Following the methodological protocol presented in our earlier
work [11,12], we then realized the multidimensional space defined
by the set of prior distributions by randomly sampling N parameter
vectors from their defined ranges. This procedure is summarized
as follows. There are 18 parameters in the model (Table 2), which
together form a parameter vector, hi. Let the i-th element of a
single parameter vector hi be defined by hii, ie, hii*U ½hminii , hmaxii ,
where hminii and h
max
ii are, respectively, the minimum and maximum
values of that element parameter hii. With each of these parameter
vectors, , the model is simulated and the posterior distribution of
model parameters p(h) obtained by fitting the model to observed
data. We then used the sampling-importance-resampling (SIR)
algorithm to resample, with replacement, from the above model
parameter sets with the probability of acceptance of each resample
hj~1,2,...,l probable to its weight Vj , which is proportional to the
corresponding likelihood L(wj) for the data, i.e.Vj~L(wj)=
P
L(wi).
A typical value of l for the results presented in this paper was around
500, and these parameter sets are then used to generate distributions
of variables of interest from the model (e.g. age-prevalence curves,
worm breakpoints, drug-related parameter values and post-treatment
infection trajectories), including measures of their uncertainties [12].
Sequential BM Model Fitting to LF Infection Data
Following Drug Interventions
The sequential BM updating approach involves three steps.
First, we fitted the model using BM to the age-mf prevalence
baseline data from each community to obtain the first pre-control
posterior distributions of the input parameters for each locality, say
p1(P), from the SIR, as discussed above. Second, we use the model
thus parameterized together with a set of drug-related model
parameter vectors (see below) to predict the state of age-mf
infection one year after the first post annual treatment. Third, we
then update the biological model parameters by applying the SIR
procedure to the first post annual treatment field age-infection
data to get a new postmodel distribution, p2(P), using as prior
inputs the posterior distributions obtained from the baseline fit.
This conditional approach thus sequentially filters the parameter
values over time with new data thereby reducing parameter
uncertainty [57]. This procedure was then applied iteratively,
adding further new post-intervention field data over time, in order
to progressively filter and thus update the initially obtained
parameter estimates [52,57].
Modelling the Effects of Annual Mass Drug
Administration
The impact of annual mass drug treatment was modelled by
assuming that anti-filarial treatment with the currently used drug
regimens acts by killing certain fractions of the populations of adult
worms and mf instantly after drug administration [7]. Assume
these fractions to be v for adult worms, and e for mf. These killing
effects are easily incorporated into the basic model and the
population sizes of worms and microfilariae are calculated after
drug treatment by modifying the populations of each parasite stage
obtained immediately prior to the treatment by:
W (a,tzdt)~(1{vC)W (a,t)
M(a,tzdt)~(1{eC)M(a,t)
)
at time t~TMDAi
where dt is a short time-period since the time-point TMDAi when
the i-th MDA was administered. During this short time-interval, a
given proportion of adult worms and mf (as specified by values of
the drug efficacy rates for these life stages, v and e, respectively)
are instantaneously killed. The parameter C is the population-level
drug coverage.
Apart from instantaneous killing of adult worms and mf,
filariasis drug regimens are also thought to reduce the production
of mf by worms surviving each MDA. Here we modeled this effect
by introducing a new parameter (denoted by dreduc) as follows:
LM(a,t)
Lt
z
LM(a,t)
La
~a’q(W (a,t),k)W (a,t){cM(a,t) ,
for TMDAivtƒTMDAizP
where a’~a(1{dreducC) reflects the suppressed fecundity (over a
period of P months since the i-th MDA) of adult worms that survive
the administration of drugs at each MDA.
The four drug-related parameters (v, e, dreduc, and P) together
with their range of non-informative prior distributions are listed in
Table 2. The first MDA round is implemented in the model
immediately after the baseline survey data is fitted, with the
remaining four MDA effects implemented annually thereafter.
Note that site-specific annual drug coverages are known for each
locality/field data set and are therefore not treated as a variable/
estimable element of the drug-related parameter vector.
Stability of Transmission Parameters and Backwards
Extrapolation of Baseline Community Infection Age-
patterns
This was carried out by fitting the dynamic model using the
sequential BM approach described above to the annual field age-
mf infection data obtained from each community following the 1st
through to the 5th year of mass drug treatments, and then running
the model for each of the l best non-drug related parameter vectors
in order to derive the mf age-prevalence equilibrium/endemic
states to be expected at baseline. The temporal stability of the
distributions of transmission parameters obtained at each time
period was determined using the univariate Kolmogorov-Smirnov
(KS) test [58], whereas we evaluated the goodness of fit of each
back calculated model prediction to observed baseline age-
infection data from each community, by calculating the so-called
Monte Carlo p-value using a modified version of the Pearson’s x2
Modelling the Effects of Mass Drug Treatments
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goodness-of-fit test described in [59]. Both age-stratified as well as
age-aggregated Monte Carlo p-values were determined in order to
evaluate the quality of model fits.
Calculation of Worm Breakpoints
We applied a numerical stability analysis approach based on
varying initial values of L* (see details of the procedure provided in
[11]), to each of the SIR selected model vectors in order to
calculate the distribution of mf prevalence breakpoints and
threshold biting rates (TBR) expected in each study community.
There are two essential steps in this approach. In the first step, we
progressively decrease V/H from its original value to a threshold
value below which the model always converges to zero mf
prevalence, regardless of the values of the endemic infective larval
density L*. The product of l and this newly found V/H value is
termed as the threshold biting rate (TBR). Once the threshold
biting rate is discovered, the model at TBR can settle to either a
zero (trivial attractor) or non-zero mf prevalence depending on the
starting value of L*. Therefore, in the next step, while keeping all
the model parameters unchanged, including the new V/H, and by
starting with a very low value of L* and progressively increasing it
in very small step-sizes we estimate the minimum L* below which
the model predicts zero mf prevalence and above which the system
progresses to a positive endemic infection state. The corresponding
mf prevalence at this new L* value is termed as the worm
breakpoint [11]. We compared the worm breakpoint values
obtained from sequential BM fits of the model to longitudinal
infection data during each year of MDA with those estimated via
direct fits to baseline age-mf infection data both formally and also
using quadratic discriminant analysis (the klaR package in R), to
determine if the sequential estimates are consistent with those
quantified directly from baseline data in each study village. As
above, the univariate KS test was used to formally test for
differences between the baseline and sequential estimates in each
case.
Results
Model Fits to Annual Intervention Data
The age-profiles of mf-prevalence generated by the Anopheline
LF model fits (grey curves) to the baseline and five annual post-
intervention data from two of the high transmission study villages
given either the DEC+IVR regimen (Peneng) or DEC alone
(Yauatong) are shown in Figure 1. The corresponding model fits
to the baseline and intervention data from the remaining three
PNG villages are shown in Figure S1 in Supporting Information
S1. Figure 2 shows the overall mf prevalences predicted by the
model in comparison with the longitudinally observed baseline
and post-intervention overall community mf prevalences recorded
for each of the five study villages. Together, these results show
clearly that the BM-based model-data assimilation method
developed in this study is capable of reproducing the temporal
changes in overall, and age-stratified, prevalences in mf, arising
from the implemented mass drug treatments consistent with
observed data in each of the study communities (Monte Carlo p-
values .0.05 in each case (Table S1 in Supporting Information
S1)), although as expected the fits to mf-age-prevalences are
comparatively better for the study villages with the lowest
variability in this infection measure, viz. Nanaha and Ngahmbule
(Figure S1 in Supporting Information S1) owing primarily to
their bigger sample sizes (Table 1).
Stability of Model Parameters
As in our previous work [12], the results show that the Bayesian
updating procedure used here when applied to baseline age-mf
prevalence data can effectively refine initially assigned model
parameter values. As indicated in Table S2 in Supporting
Information S1, almost all the values initially assigned to the
present model parameters were updated by the procedure,
although as also noted previously [12], an important finding is
that this was dependent on study sample size, with increasing
changes in the posterior distributions occurring for those study
communities (e.g. Nanaha, Ngahmbule) with the larger sample
sizes. Across all study sites, however, only six parameters, namely,
a, kLin, y2s2, c, IC and SC, which represent the fecundity rate per
worm, the linear rate of increase in the aggregation parameter, the
parasite establishment rate, the strength of acquired immunity to
L3 larvae, the strength of immunosuppression and the slope of
immunosuppression function, respectively, were consistently found
to have their posterior distributions significantly altered from their
assigned non-informative uniform prior distributions when the
model was fitted to the baseline data (Figure 3). We next
simulated the effects of each MDA regime using actually observed
community drug coverage rates, and used the fits of these
simulations to data from each study village to assess if the values of
any of these biological/ecological parameters remained temporally
invariant. The results demonstrated that these six parameters
remained remarkably fixed throughout the intervention period in
all study sites (Figure 4), with their posterior distributions
retaining the same individual baseline distributional shapes in
each case. A more formal test of how stable or robust to
perturbations all the model parameters, including these six model
parameters, were during the 5-year post-treatment period was
carried out using the univariate KS test [58]. This indicated that
almost all the biological parameters of the model remained at their
initial baseline posterior distributions during the entire 5-year
study period when infection in each of the five LF communities
were going through their annual intervention-induced perturba-
tions (Table S2 in Supporting Information S1).
Estimation of the Drug Efficacy Related Parameters
As noted above, the LF drug efficacy related parameters are (1)
instantaneous worm killing efficacy: this is major parameter with
values assigned previously based on either on expert advice [7], or
limitedly estimated from the field data using a mechanistic
transmission model (see [26]); (2) microfilariae killing efficacy:
better information available from published community trials
where values from 69.8% to 91.1% have been demonstrated
previously [30,60]; (3) suppressed production of mf by worms
surviving MDA, and (4) the waning period: this is the short time-
period that follows the commencement of mass drug administra-
tion during which the drug is assumed to remain effective, which is
expected to range from between 3 to 9 months [7]. The summary
statistics of their estimated posterior parameter distributions in this
study indicate gains in knowledge for these parameters from the
sequential updating of the LF model, with all parameters in
general showing shifts from their assigned prior distributions as
interventions progressed (Figure 5, Figures S2, S3, S4 and
Table S3 in Supporting Information S1). The biggest and most
informative posterior distribution shift, however, occurred for the
worm killing efficacy parameter, with efficacy rates increasing to
apparently settle around a peak mean rate of 74 to 77%
(Figure 5). Mean efficacy rates also increased with sequential
model updates for the microfilariae killing and waning period
parameters to approximately 80% and 4 months respectively by
year 5 post-intervention, although these increases were not found
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to be statistically significant. The least change occurred for the
worm fecundity reduction parameter. Interestingly, the addition of
IVR to DEC did not appear to significantly change the model
estimated drug efficacy parameter distributions indicating that the
major impact on reducing LF infection using the combination
therapy is due to the effects of DEC. By contrast, an intriguing
finding was that the mean worm killing rate became marginally
higher with increasing cycles of intervention in the villages exposed
to the low (Nanaha, Ngahmbule) compared to the high (Peneng,
Albulum, Yauatong) transmission intensity (Figure 5).
Backfitting to Reconstruct LF Baseline Data
We carried out this analysis to test the hypothesis that if the
biological parameters of the model (i.e. not drug efficacy
parameters) remained stable or are invariant during the interven-
tion period for a site, then it will be possible to use the sequential
fits to reconstruct that site’s baseline age-infection profile. The mf-
prevalence curves generated by sequential model fitting/updates
to the age-infection data following each of the five annual drug
interventions from year 1 post-intervention (left panel), and their
usefulness for reconstructing baseline infection (right panel) are
shown in Figure 6 for the village of Peneng (similar findings were
obtained for all the rest of the study villages and are shown in
Figures S5, S6, S7, S8 in Supporting Information S1). All of the
individual sets of l ( = 500) parameter vectors were used to simulate
the baseline age-profiles of mf-prevalence, and the posterior
individual curves, medians, and their 95% credible intervals from
these simulations are plotted in the figure. The results depict that,
although there are year-to-year variations in the backfitted age-mf
profiles, the sequentially fitted parameter vectors from each
individual year are able to recover the baseline situation
remarkably well. Table 3 provides the age-stratified and overall
Monte Carlo p-values for the fits of each the backward
extrapolations to the example Peneng baseline infection data.
The results indicate that model performance for recovering the
baseline LF infection for this study site was excellent, when
evaluated using age-aggregated data whereas when assessed
against age-stratified baseline data discrepant results were
obtained for only the youngest 0–10 age group. Similar results
Figure 1. Predicted age-profiles of mf-prevalence from model fits to observed baseline and longitudinal post-intervention
infection data. Model outputs and observed data are shown for two of the PNG study villages exposed to high LF transmission intensity, and for
both drug regimens used: Peneng (DEC+IVR) and Yauatong (DEC alone). Individual 500 best-fit model simulations are shown in grey while the thick
blue line represents the median value of these curves. The observed data points (crosses) with 95% binomial credible intervals are shown at the mid-
points of each 10-yearly age-group. The results for the remaining three study villages are exactly similar (Figure S1 in Supporting Information).
doi:10.1371/journal.pone.0067004.g001
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were obtained for the rest of the study villages (Table S4 in
Supporting Information S1).
Worm Breakpoint Comparisons
Figure 7 depicts and compares the mf breakpoint values
obtained from the stability analyses of the directly (i.e. fitted only to
baseline data) versus 1) sequentially fitted LF models to the year 1,
3 and 5 post-MDA data, and 2) a situation reflecting either a 25%
or a 50% overall reduction in initial annual biting rate over the
entire 5-year MDA period, both for the study village of Peneng.
The results from the plotted quadratic discriminant analyses show
clear separation between breakpoint values estimated retrospec-
tively using backfitted models compared to those calculated from
the direct fits to baseline data only in the case when the initial
biting rate is reduced by 50% over the entire MDA period.
Reduction of annual biting rate by 50% also raised worm
breakpoint values and generated lower threshold biting rates
(Figure 7F). The formal KS test underscored these results
indicating a significant difference (p= 0.0042) only for the direct
versus backfitted estimates in the case of the 50% reduction in the
biting rate scenario. Similar findings were also obtained for the rest
of the study villages (data not shown).
Discussion
In our previous work, we had highlighted the importance of
assimilating locality-specific LF infection data into process-based
mathematical models as a strategic framework for determining LF
elimination endpoints that best reflect the realities of transmission
in local environments [12]. Here, we extend that work by
investigating if the biological parameters underlying LF transmis-
sion estimated by calibrating mathematical models using baseline
pre-intervention data in a field site are robust to infection
perturbations induced by drug regimens applied sequentially at
that site. This is an important question of practical significance to
the current drug-based LF elimination program, because if these
model parameters are found to be dynamically variable then
parasite infection dynamics, including endpoint values, are likely
to also vary as interventions proceed. This would make predictions
of when elimination may be achieved commensurately more
difficult, besides indicating a need for adaptively revising
intervention schedules (e.g. duration, frequency of MDAs) period-
ically as programs progress. On the other hand, if the parameters
in a site undergoing interventions are found to be stable in the face
of perturbations, then this robustness would likely enhance
achievement of LF elimination since it would imply that endpoints
estimated from either baseline or monitoring data during
interventions are exchangeable, and therefore either could serve
as reliable targets for determining parasite extinction.
The major result of this study viz. that the biological parameters
underpinning LF transmission may indeed remain dynamically
stable at least over a moderately long MDA program (5 years) in
individual endemic localities, may therefore represent an outcome
of import to the current LF elimination initiative. This result
suggests: 1) that LF extinction dynamics and hence elimination
endpoints in different sites are unlikely to vary over the durations
of MDA expected to bring about parasite elimination in most
endemic communities [7,12], 2) that endpoint values may be
estimated equally reliably from either baseline pre-MDA or from
intervention monitoring data depending on data availability in a
site, and finally, 3) that monitoring data during a MDA may be
used to reliably back calculate or hindcast initial baseline age-
infection patterns, thereby allowing generation of the expected
system trajectories required for evaluating the progress made
towards LF extinction for all those sites without such data [27,29].
Taken together, these new findings enhance the prospects of LF
elimination as they signify that once endpoints and original
infection are known/estimated for a site, initially specified optimal
intervention schedules and parameters (e.g. coverage/duration of
MDA) for crossing such endpoint targets may be followed without
alteration until the end of the program, thereby significantly
simplifying the management of parasite control [27,29].
The finding of temporal invariance or dynamic stability in key
biological parameters in this study has also shed intriguing new
insight into the nature of LF transmission in endemic communi-
ties. In particular, it supports recent work exploring the design of
biological systems, which suggests that such invariance in
biological parameters could be a direct function of the structural
adaptation of a complex biological system, such as LF, to initial
ecological conditions of a locality so that maintenance of system
function (parasite transmission in the present case) against
Figure 2. Comparison of the trends in overall community-level
mf prevalence predicted by the model with the observed
baseline and post-intervention infection data collected longi-
tudinally during the mass treatment programme. Model outputs
and observed infection data are shown for all the five PNG study
villages. The observed overall community prevalence collected at a
yearly interval from each study site are depicted by empty red squares
together with their corresponding 95% binomial credible intervals
(bars). The baseline data (at the 0th year in 1993–94) were collected
soon before the start of the first mass drug administration round, and
the five post-intervention mf prevalence data were collected annually a
year after each mass drug treatment from the first through the 5th MDA
round (see Table 1). Note that there are 500 modelled data points
(shown by empty cyan circles) from the 500 best fits.
doi:10.1371/journal.pone.0067004.g002
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perturbations are preserved locally [19–23,61]. This perspective
suggests that the remarkable observed persistence of LF transmis-
sion in the face of the drug perturbations carried out in the PNG
study sites could be a direct outcome of the complex biological
architecture which underpins the transmission of vector-borne
diseases - viz. diverse regulatory feedback loops that are able to
compensate for changes in ecological conditions, diversity and
modularity in overall transmission function by involving two hosts
and heterogeneous mosquito larval habitats, which can help
contain perturbations locally to minimize effects on the whole
system, and different parasite stages exhibiting markedly different
life spans to buffer interactions against perturbations [21,23] -
adapted to be robust to normal variations in the values of key
transmission-related ecological factors prevailing in a given
locality. This implies that if LF transmission parameters are
stable, then initial conditions will set the boundaries of local
transmission dynamics [21,23,61]. Recent studies in schistosomi-
asis modelling have also highlighted the impact and need for
estimating site-specific internal determinants of parasite transmis-
sion for gaining a better understanding of the population dynamics
and control of Shistosoma japonicum in endemic communities
[52,56,62]. This finding, together with the present results, indicate
firstly that robustness to initial conditions in a site may be a
fundamental structural feature of vector-borne, and possibly other,
parasitic transmission systems, and secondly that gaining a better
understanding of the mechanisms underlying such dynamics will
be fundamental to identifying the faults and hence the effective
countermeasures required to disrupt parasite transmission reliably.
However, it is clear that a trade-off arising from such dynamics
is that locally robustly adapted systems may also face devastating
fragilities in the face of novel environmental conditions or
perturbations leading to catastrophic system failure [21,23,61].
Here, we have demonstrated that one major initial external factor
that may confine LF dynamics over time in an endemic locality is
vector abundance (Figure 7). The available data on changes in
entomological variables over the 5 year MDA period in each
village showed yearly fluctuations that were most prominent for
the high transmission villages studied here [30]. Our analysis of the
impact of these fluctuations depicted in Figure 7 shows that LF
transmission robustness could be sensitive to such vector abun-
dance changes, but only when .50% change occurred in this key
variable over an intervention period. By contrast, when fluctua-
tions in vector biting rates came close to but not.50% (as actually
recorded for the high transmission study villages examined here
[30]), LF transmission robustness was maintained. This finding
indicates that model calibration to key local variables, such as
vector biting rates, may allow detection of the boundaries or
thresholds of the specific initial constraining conditions that
confine dynamics to a site. A major question in this regard is
then whether once the values of this confining variable traverse
such thresholds, this change might shift the transmission dynamics
(and associated attractors, basins of attraction and stability) of the
historically adapted LF system into a new and possibly more
fragile transmission state and push the system into extinction [20].
Our investigation of this question with regard to changes in vector
biting rate has indicated that this outcome might be a distinct
possibility in the case of LF. This is illustrated in Figure 7F, which
shows that if the initial bounding vector abundance variable in a
site is reduced over time by a large degree (.50%), fragile LF
transmission regimes may indeed emerge as demonstrated by the
shifts to higher worm endpoints and lower TBR values in the
figure. This finding presents a new mechanism in support of our
previous conclusion from modelling intervention dynamics
regarding the role of vector control in LF elimination, viz. that
Figure 3. Posterior distributions of model parameters. The results are shown for 6 model parameters, a, kLin, y2s2, c, IC and SC, whose
posteriors changed significantly and consistently from their initially assigned uniform priors when the LF model was fitted to the baseline data in
each study village. The results in the figure illustrate the estimated posterior parameter shifts for the village of Peneng. Dashed lines show the flat
non-informative priors, while the bars denote the frequency distributions of the posterior values for each parameter. The parameter values along the
x-axis are normalized for comparative purposes. The figures in square brackets at the top of each plot depict the actual range of the posterior values
estimated for each parameter.
doi:10.1371/journal.pone.0067004.g003
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including vector control into MDA programs can significantly
accelerate the achievement of parasite elimination by altering both
vector transmission and worm breakpoint thresholds negatively
[7,9,13].
The sequential BM fitting of the anopheline-mediated LF model
to longitudinal mf data from each of the study villages has also
shown that the temporal invariance observed for the biological
parameters of this model was compensated for by the occurrence
of significant changes in all of the corresponding drug-related
parameters relevant to modelling the impact of the drug regimens
used in each site, viz. DEC alone or combined DEC/IVR. The
estimated posterior distributions for each of four drug parameters
–1) worm killing efficacy, 2) mf killing efficacy, 3) reduced
fecundity of surviving worms and 4) the waning period – showed
variable shifts from their initially assigned prior distributions in
each site, with the most informative change observed for the worm
killing efficacy parameter, the mean rates of which appearing to
settle around values of between 74 to 77% for the two drug
regimens by the end of 5 MDA cycles in these study villages
(Figure 5). Similarly, mean efficacy rates for mf killing and the
waning period parameter increased to peak values of around 80%
and 4 months respectively over the same intervention period.
These sequential model estimates indicate that while previous
estimates of the mf killing and waning rates for the present drug
regimens appear to have been generally well defined [7,26], the
worm killing rate, by contrast, has been grossly underestimated,
suggesting that previous modelling results of the impact of MDA
may have been overly pessimistic. Furthermore, the results also
show that the addition of IVR to DEC does not appear to
markedly change the estimate for this parameter in comparison to
the effects of the DEC only regimen. Thus, our results indicate
that the major impact of the combination therapy in reducing LF
infection in field settings is attributable mostly to the effects of
DEC. This finding implies that regimens with IVR but without
DEC, such as the ivermectin/albendazole (IVR/ALB) combina-
tion regimen advocated for use in many parts of Africa with co-
occurring onchocerciasis [1], will have a comparatively lower
impact - indeed there is some evidence that ALB would also
further lower the efficacy of this combination by an inhibitory
effect on worm killing [63] - in reducing LF transmission, thus
Figure 4. Stability in model parameters during intervention period. Comparison of changes in the posteriors of the parameters a, kLin, y2s2,
c, IC and SC obtained via sequential model fitting to annual infection data recorded over the 5-year intervention period in the high transmission
villages of Peneng and Yauatong. Solid coloured lines denote of the relative frequencies of the posterior distributions of each of the six model
parameters. The x-axis shows the scaled values of the posterior distributions for each parameter. The dashed line shows the initially assigned flat non-
informative priors.
doi:10.1371/journal.pone.0067004.g004
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making parasite elimination more difficult to achieve in such areas.
Note that such an inhibitory effect may also reduce the worm
killing efficacy of DEC in the DEC/ALB combination, which
would clearly have implications for LF elimination in other areas;
more biological details of this effect or data from sites using the
DEC/ALB combination regimen will need to be modeled if we are
to better estimate such inhibitory effects. A further complication
highlighted by our results regarding the effectiveness of MDA is
that there may also be a density-dependent effects on worm killing
by both the applied DEC and DEC/IVR regimens, with the mean
worm killing rate estimated for each regimen being marginally
lower at each cycles of intervention in the villages exposed to the
high compared to the lower transmission intensity (Figure 5). The
import of this result is clear: worm killing efficacy of anti-filarial
drug regimens will vary with the intensity of infection in a
community. These findings further emphasize the crucial require-
ment for estimating transmission and intervention parameters that
reflect local realities of transmission if LF is to be reliably
eliminated from endemic communities. They also underscore the
importance of including supplementary measures, such as vector
control, to MDA, this time both to overcome the effects of using a
less efficacious macrofilaricidal regimen in DEC contra-indicated
regions and to overcome the possibility of density-dependent
worm killing effects, if we are to achieve LF elimination globally.
Our use of the BM methodology to integrate sequential
intervention-related infection data with the LF model to predict
the effects of MDA on infection dynamics show that this Monte-
Carlo based Bayesian calibration method can yield results that
efficiently approximate reality as close as possible. As highlighted
previously [51,54], the innovative benefit using this approach
rather than simple Monte Carlo simulations lies in the ability to
attach prior distributions and calculate likelihoods for both model
input and the output, which improves the use of data to inform
initial conditions, update model parameters, and constrain a
model during simulation so to match observed data closely.
However, one drawback of using sampling filters such as the SIR
algorithm used in this study to generate the posterior probability
distributions of model parameters and predicted state variables (e.g.
endpoints) is that it may lead to sample impoverishment, wherein
the posterior sample may have a large number of repeated copies
due to the weighted resampling carried out based on likelihoods of
parameter vectors [64–66]. Although this did not represent a
major problem in the present study, future applications of this
approach to extended datasets and perhaps fitting of models to
data from longer MDA cycles than studied here will need to take
this technical issue into consideration. Parasite system dynamics,
particularly in the case of vector-borne diseases, are also likely to
be strongly influenced by weather and climate changes via effects
on vector population dynamics. As shown in this study, such vector
abundance changes can critically impact parasite transmission
dynamics in a locality, meaning that future studies may require
considering statistical frameworks, such as Markov Chain Monte
Carlo (MCMC) methods or hybrid sequential Monte Carlo
sampling/MCMC approaches, for joint estimation of time varying
parasite system states and parameters [57,64,66,67]. We are
currently extending our LF model to explicitly include mosquito
Figure 5. Peak shift in the estimated worm killing efficacy rate of the two drug regimens. Horizontal lines depict the prior parameter
distribution, which was assigned to vary from 10% to 85%. Bars represent the estimated relative frequencies of the parameter obtained by annual
sequential model fits to data through the 5-year intervention period in each of the 5 PNG study villages. The vertical lines represent measures of the
central tendency of the estimated posterior distributions: mean (broken line) and median (solid line).
doi:10.1371/journal.pone.0067004.g005
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population dynamics (rather than using a fixed ABR value to
represent such dynamics as performed here) as a first step to
developing such statistical methods. Note also that if it is
confirmed that local LF transmission dynamics can be largely
constrained by the prevailing vector abundance in a site, another
outcome of such a finding is that it may also allow the application
of our model, and hence transferability of results, across different
settings based on calibration to available joint spatial data on
vector biting rates and mf prevalences.
A further improvement to our modelling approach is to directly
include infection diagnostic uncertainties into the model calibra-
tion approach so that true prevalences can be quantified from joint
estimates of test specificities and sensitivities [68,69]. This will
clearly be important in correcting for endpoint values estimated
using different types of infection indicators as well as for correctly
predicting the corresponding system trajectories due to the
application of MDA in different localities [27]. Such work will
improve understanding of how indicator dynamics are linked to
the underlying parasite transmission dynamics, and in turn guide
the choice of the best indicators that closely match worm dynamics
for monitoring the impact of interventions on LF infection/
transmission in communities [27,29].
Figure 6. Sequential model backfitting to baseline infection data. Comparisons of sequential model fits to observed annual declines in mf
age-prevalence (left panel), and of back predictions of each yearly fit to observed baseline infection data for the village of Peneng (right panel).
Sequential parameter updating was accomplished by using posteriors from the model fit to a previous year as priors for each successive subsequent
year, starting with the posteriors obtained by model fitting to year 1 intervention data (see text). The thick (blue) line represents the median value of
the SIR selected 500 prevalence curves. The observed annual declines in mf age-prevalence (left panel) and baseline mf age-prevalence (right panel)
respectively are shown by crosses with 95% CIs. The dashed lines in the right-panel plots represent the 95% bounds (the 2.5th and 97.5th percentile
values) of the simulated mf-prevalence curves shown in grey. Similar results were obtained for the remaining 4 study villages (Figures S5, S6, S7,
S8 in Supporting Information).
doi:10.1371/journal.pone.0067004.g006
Table 3. Monte Carlo p-values for the backfitted models to
the Peneng baseline data.
Age-stratified and overall Monte Carlo p-values
Year 0–10 10–20 20–30 30–40 40–50 50–60 Overall
* 0.735 0.841 0.998 0.112 0.998 0.213 0.988
1 0.055 0.842 0.996 0.118 0.996 0.199 0.984
2 0.034 0.84 0.998 0.13 0.998 0.166 0.978
3 0.082 0.812 0.998 0.056 0.986 0.277 0.98
4 0.018 0.854 0.999 0.186 0.999 0.164 0.98
5 0.046 0.841 0.998 0.112 0.998 0.213 0.988
(*) The p-values are calculated for the model fits directly fitted to the baseline
data. The numbers in the first column represent the intervention years. In this
case, the posteriors of the non-drug parameters, obtained from the sequential
model fits to those years’ post-intervention infection data, were used to
reconstruct the baseline.
doi:10.1371/journal.pone.0067004.t003
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Despite these limitations related to our current model and its
calibration, the present study has nonetheless advanced new
understanding regarding LF transmission and the prospects for its
control using currently available MDA methods. Firstly, our
findings underscore the need to understand the biological
robustness of parasite transmission, and the factors that underlie
such robustness, in local settings if we are to develop reliable
countermeasures to achieve parasite extinction. Our preliminary
analysis of LF transmission robustness to initial conditions has
highlighted the impact that fluctuations in vector abundance can
play in pushing a locally robustly adapted vector-borne parasite
system to a different state with its own dynamics, and hence
endpoints. This result corroborates previous theoretical and
experimental work in demonstrating that adaptability or robust-
ness of biological systems, including complex parasitic systems, to
one set of conditions can enhance their fragility to abrupt changes
in such conditions [19–23,61]. We suggest that learning about
these trade-offs between transmission robustness and fragility has
now become central if we are to successfully accomplish the
elimination of LF, and indeed other parasitic infections, both
locally and globally. Secondly, results presented here also suggest
that progress in this next generation of work will not only require
the development of modelling methods to analyse and evaluate
biocomplexity and robustness of parasitic systems, but also the
development of data-driven inferential techniques that can reliably
allow the joint determination of model states, structure and
calibration using local data. A key need here is the development of
modelling frameworks that can assimilate spatially distributed data
on key ecological conditions relevant to parasite transmission from
a variety of sources, couple with climate and weather dynamics,
and integrate with the available spatio-temporal datasets on
human infection prior, during and following interventions [57,67].
Constructing such models of everywhere is no doubt a daunting
challenge, but we suggest that with the rapid improvement in
computing power, advent of new intelligent eco measurement
devices and observation networks, and development of new
flexible state space data modelling and assimilation approaches,
these challenges can be met [57,67], and the notion of using
models as an effective management tool for achieving parasite
control or eradication becomes an attractive, acceptable option.
Lastly, a theme that can be identified running throughout this
work is a need for control programs to focus on obtaining good
quality infection monitoring data. Data will be required to
characterize local dynamics, to evaluate and update model
predictions, extrapolate predictions to sites without or poor quality
data, and monitor changes in coverage and system response as
interventions progress. We end by indicating that a closer
alignment of modelling work with well-collected field data
constitutes an urgent operational requirement if the current global
program to eradicate LF is to successfully achieve its laudable goal.
Supporting Information
Supporting Information S1 File contains eight figures and four
tables: Figure S1 - Predicted age-profiles of mf-prevalence
(curves) from model fits to observed baseline and
longitudinal post-intervention infection data for the high
transmission village of Albulum (DEC+IVR), and the low
transmission villages of Nanaha (DEC+IVR) and
Ngahmbule (DEC alone). The observed data points (crosses)
with 95% binomial credible intervals are shown at the mid-points
of each population age-group. Individual 500 best-fit model
simulations are shown in grey while the thick blue line represents
the median value of these curves. Figure S2 - No significant
changes in the estimated mf killing efficacy rate over
time. Horizontal lines denote the frequency distribution of the
parameter prior, which was assigned to vary from 55% to 95% in
each village. Bars represent the relative frequencies of the
parameter posteriors obtained from the model fits to the infection
over the intervention period. The vertical lines depict measures of
the central tendency of the estimated posterior distributions: mean
(broken line) and median. Figure S3 - No significant changes
in the estimated worm fecundity reduction rate. Hori-
zontal lines and bars are as described in the previous figure. The
prior distribution was set to vary from 55% to 95% in each village.
The vertical lines are the estimated means and medians of the
posteriors. Figure S4 - No significant changes in the
waning period. Horizontal lines and bars are as described
before. The prior distribution of the waning period was set to vary
from 1 to 6 months in each village. The vertical lines are the
estimated means and medians of the posteriors. Figure S5 -
Sequential backfitting to baseline data of the village
Albulum. As shown in Figure 6 in the main text, the thick (blue)
line represents the median value of the SIR selected 500
prevalence curves. The observed annual declines in mf age-
prevalence (left panel) and baseline mf age-prevalence (right panel)
respectively are shown by crosses with 95% CIs. The dashed lines
in the right-panel plots represent the 95% bounds (the 2.5th and
97.5th percentile values) of the simulated mf prevalence curves
shown in grey. Figure S6 - Sequential backfitting to
baseline data of the village Yauatong. Descriptions of the
data shown (denoted by symbols, bars and curves) as given in the
legend to Figure S5. Figure S7 - Sequential backfitting to
baseline data of the village Nanaha. Descriptions of the data
shown (denoted by symbols, bars and curves) as given in the legend
to Figure S5. Figure S8 - Sequential backfitting to baseline
data of the village Ngahmbule. Descriptions of the data
shown (denoted by symbols, bars and curves) as given in the legend
to Figure S5. Table S1 - Monte Carlo p-values for the
directly fitted models to the baseline and five post-
intervention infection data collected during mass
Figure 7. Comparison of results from carrying out a quadratic discriminant analysis on worm breakpoints and threshold biting
rates estimated from direct- and back-fitted LF models to baseline mf age-prevalence data for Peneng village. In (A) the endpoint data
(worm breakpoints and biting thresholds) estimated by direct model fits to the baseline mf age-prevalence data (shown by 0) are compared against
endpoint estimates derived from the reconstructed baseline mf age-prevalence obtained via model fitting to the first year intervention data (shown
by 1). Similarly, in (B) and (C) the directly fitted model estimates are compared against those obtained from backfitted mf age-prevalences using,
respectively, the third (denoted by 3) and fifth (denoted by 5) years’ intervention data. In the right panel, the endpoint estimates from the model
fitted directly to baseline infection data are compared against those estimated from the backfitted models using the fifth year intervention data, but
with the original annual biting rates increased by 25% (shown by 6) in (D), reduced by 25% (shown by 7) in (E), and by 50% (shown by 8) in (F). The
edges between the two coloured regions in each graph depict the separation boundaries for the direct and back-fitted endpoint estimates in each
case. The two solid dots in each plot depict the means of the distributions of the endpoint estimates obtained from the direct- and the back-fitted
models to the baseline data. Note that the two dots begin separating from each other but still remaining in the same coloured region in (E), with full
separation between the two estimated distributions (i.e. falling in a distinct coloured region) occurring only in (F).
doi:10.1371/journal.pone.0067004.g007
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treatment programme for the five PNG study sites.
Table S2 - Results of the univariate Kolmogorov-
Smirnov (KS) test of differences between the parameter
posterior distributions estimated from sequential mod-
el fits to baseline and infection data from five successive
years. The p-value shows the significance level of the KS test. A
p-value ,0.05 indicates that posterior distribution is significantly
different from its prior. Here the parameter posteriors from the
models fitted to the baseline were tested against the non-
informative priors. The parameter posteriors from the models
fitted to the infection data of the first intervention year were tested
against those from the model fitted to the baseline data of each
study site; the parameter posteriors of the second intervention year
against those of the first year; and so on. Table S3 - Results of
the univariate Kolmogorov-Smirnov (KS) test of differ-
ences between prior and posterior distributions of drug
related parameters. The p-value shows the significance level of
the KS test. A p-value ,0.05 indicates that posterior distribution is
significantly different from its prior, which is always the case for
the worm killing efficacy parameter.
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